Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
08/2010
08/19/2010WO2010054114A3 Cycloalkane[b]azaindole antagonists of prostaglandin d2 receptors
08/19/2010WO2010054113A3 Cycloalkane[b]azaindole antagonists of prostaglandin d2 receptors
08/19/2010WO2010033495A3 Functionally selective azanitrile alpha2c adrenoreceptor agonists
08/19/2010WO2009122034A8 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
08/19/2010US20100210762 Heterocyclic compound, ultraviolet absorbent and composition containing the same
08/19/2010US20100210685 Novel Substituted Indoles
08/19/2010US20100210678 Tricyclic androgen receptor modulator compounds and methods
08/19/2010US20100210674 Spiroindolinone Derivatives
08/19/2010US20100210665 Diarylhydantoin compounds
08/19/2010US20100210644 Chemical compounds
08/19/2010US20100210641 Organic Compounds
08/19/2010US20100210634 Certain Chemical Entities, Compositions and Methods
08/19/2010US20100210629 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
08/19/2010US20100210622 Heterocyclic compounds and methods of use
08/19/2010US20100210610 Organic compounds
08/19/2010US20100210606 Methods and reagents for the treatment of inflammatory disorders
08/19/2010US20100210599 Prodrugs of piperazine and substituted piperidine antiviral agents
08/19/2010US20100210476 Pyrrolo[2,3-b]Pyridine Derivatives Active as Kinase Inhibitors and Pharmaceutical Compositions Comprising Them
08/19/2010US20100210451 Catalysts and methods for catalytic oxidation
08/19/2010US20100210036 Ppar active compounds
08/19/2010US20100209345 Fluorinated Ligands for Targeting Peripheral Benzodiazepine Receptors
08/19/2010US20100209340 Pyrido [2, 3-d] pyrimidin-7-one compounds as inhibitors of p13k-alpha for the treatment of cancer
08/19/2010US20100207108 Electronic device including phenanthroline derivative
08/19/2010US20100207072 Use of rylene derivatives as active components in solar cells and photodetectors
08/19/2010DE102009008661A1 New micellar nanoparticle comprising anthra(2,1,9-def;6,5,10-d'e'f')d iisoquinoline-1,3,8,10-tetraone compound useful e.g. in data storages, preferably in optical storage e.g. compact disc or DVD discs, organic-LED and photovoltaic device
08/19/2010CA2752073A1 Histamine h3 inverse agonists and antagonists and methods of use thereof
08/19/2010CA2751517A1 [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors
08/19/2010CA2751501A1 2-morpholino-pyrido[3,2-d]pyrimidines
08/19/2010CA2751478A1 Derivatives of azaindoles as inhibitors of protein kinases abl and src
08/19/2010CA2751243A1 Spiroindolinone pyridine derivative
08/19/2010CA2750913A1 Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1
08/18/2010EP2218464A1 Compounds for non-invasive measurement of aggregates of amyloid peptides
08/18/2010EP2218463A1 Use of novel compound having affinity for amyloid, and process for production of the same
08/18/2010EP2218330A1 Process for the preparation of 2-ethyl-4,6-dimethylphenyl acetic acid by reacting 2-ethyl-4,6-dimethylbromobenzene with tert.-butylacetate
08/18/2010EP2217600A2 Fungicidal bicyclic pyrazoles
08/18/2010EP2217599A1 Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes
08/18/2010EP2217598A1 New tetracyclic compounds
08/18/2010EP2217596A2 Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119
08/18/2010EP2217590A1 Pyridopyrimidine derivatives as pi3 kinase inhibitors
08/18/2010EP2217569A1 Enantioselective process for preparing a substituted alkanoic acid
08/18/2010EP2217568A1 Compounds for inhibiting ksp kinesin activity
08/18/2010EP1979355B1 Spiro imidazole derivatives as ppar modulators
08/18/2010EP1845978B1 Substituted pyrazolo-pyridines, compositions containing them, method for the production thereof, and their use
08/18/2010EP1737842B1 Selected cgrp antagonists, method for producing the same and the use thereof as drugs
08/18/2010CN101809020A Perharidines as CDK inhibitors
08/18/2010CN101809016A Gamma secretase modulators
08/18/2010CN101808995A Novel glucokinase activators and methods of using same
08/18/2010CN101808994A Compounds and methods for kinase modulation, and indications therefor
08/18/2010CN101808988A Piperidine and piperazine derivatives
08/18/2010CN101805298A Novel aryl- and heteroarylpiperazines
08/18/2010CN101274933B Dipyrene-3,4,6,7:12,13,15,16-octacarboxylic tertimide compound and preparation thereof
08/18/2010CN101270119B Technique for purifying spherosinin from leguminosae pointvetch or milk vetch
08/17/2010US7777051 A compound with azo containing mono and a bicyclic rings attached with an aryl or heteroaryl ring; both therapeutic and diagnostic
08/17/2010US7777041 N-(4-(5-Butyl-2-methoxyphenyl)-1,3-thiazol-2-yl)-4-((4-oxopiperidin-1-yl)carbonyl)benzamide; antiinflammatory, anticarcinogenic, antidiabetic, analgesic agents
08/17/2010US7777035 Azaindazole compounds and methods of use
08/17/2010US7777032 N-4-[3-Chloro-4-(3-fluoro-benzyloxy)-phenyl]-N6-(3-ethyl-oxazolidin-2-ylidene)-quinazoline-4,6-diamine; use as type I receptor tyrosine kinase inhibitor; hyperproliferation diseases such as cancer; antiinflammatory agents
08/17/2010US7776909 such as (5-acetyl-1-methyl-1H-pyrrol-2-yl)acetyl methanesulphonamide, used for the of treatment of psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD), skin disorders, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis and reperfusion injuries after ischemia
08/17/2010US7776906 Fungicidal active compound combinations
08/17/2010US7776885 Benzimidazolone compounds having 5-HT4 receptor agonistic activity
08/17/2010US7776879 anticholinergic agents such as Butylthiophen-2-ylmethylcarbamic acid 1-azabicyclo[2.2.2]oct-3-(R)yl ester, having a high affinity for muscarinic M3 receptors, useful for treating respiratory system, urogenital, gastrointestinal and cardiovascular disorders
08/17/2010US7776875 such as 2'S,3S,4'R)-6-chloro-4'-{5-chloro-2-[1-methyl-1-(1-methyl-piperidin-4-ylcarbamoyl)-ethoxy]-phenyl}-2'-(5-fluoro-2-methyl-phenyl)spiro[3H-indole-3,3'-piperidine]-2,6'(1H)-dione, used as antiproliferative agents, especially, as anticarcinogenic agents
08/17/2010US7776874 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
08/17/2010US7776864 Fused bicyclic pyrimidines
08/17/2010US7776833 as neuroprotectants for improving of cognitive function and for normalization of psychophysiological status, as well treatment of a of psychological and cardiovascular disorders, diseases caused by substance abuse and a hyperactive immune system in mammals
08/17/2010US7776568 Methods and kits using extended rhodamine dyes
08/17/2010US7776182 8-Oxyl-7,7,9,9-tetramethyl-1,3,8-triaza-spiro[4.5]decane-2,4-dione; antiyellowing agents for lignin
08/17/2010CA2481535C Use of ep4 receptor ligands in the treatment of il-6 involved diseases
08/17/2010CA2472372C Hydroxynaphthyridinone carboxamides useful as hiv integrase inhibitors
08/17/2010CA2382940C 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands
08/12/2010WO2010091310A1 Inhibitors of jun n-terminal kinase
08/12/2010WO2010091104A1 Glucosylceramide synthase inhibitors
08/12/2010WO2010090716A1 Heteroaryls and their use as pi3k inhibitors
08/12/2010WO2010090347A1 Dihydroquinolinone derivatives
08/12/2010WO2010090077A1 Organic electroluminescent element, and illumination device and display device each comprising the element
08/12/2010WO2010089993A1 Ring-fused 2-pyridone derivatives and herbicides
08/12/2010WO2010089686A1 4-amino-7,8-dihydropyrido[4,3-d]pyrimidin-5(6h)-one derivatives
08/12/2010WO2010089685A1 4-amino-7,8-dihydropyrido[4,3-d]pyrimidin-5(6h)-one derivatives
08/12/2010WO2010089127A1 Substituted spiro-amides as b1r modulators
08/12/2010WO2010089119A1 Heterocyclic derivatives as m-glu5 antagonists
08/12/2010WO2010089084A1 Substituted indole compounds as bradykinin receptor 1 modulators
08/12/2010WO2010067085A3 Synthesis of 9-(arylalkyl)-1,2,3,4-tetrahydro-υ-carboline and analogues and intermediates
08/12/2010WO2010011546A3 Pyrrolo [3, 2-b]pyridines and pyrazolo [4, 3 -b] pyridines having 5-ht6 receptor affinity
08/12/2010WO2009097287A8 Compounds and compositions as kinase inhibitors
08/12/2010US20100204475 N-Type Semiconductors and Related Devices
08/12/2010US20100204265 Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections
08/12/2010US20100204257 Spiroindolinone pyridine derivatives
08/12/2010US20100204246 5-aminopyrazol-3-yl-3h-imidazo (4,5-b) pyridine derivatives and their use for the treatment of cancer
08/12/2010US20100204240 Pyridin-2-YL-Amino-1, 2, 4-Thiadiazole Derivatives as Glucokinase Activators for the Treatment of Diabetes Mellitus
08/12/2010US20100204239 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
08/12/2010US20100204238 BICYCLIC NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
08/12/2010US20100204236 Substituted imidazoles as bombesin receptor subtype-3 modulators
08/12/2010US20100204225 Organic compounds
08/12/2010US20100204224 Azacyclic compounds as inhibitors of sensory neurone specific sodium channels
08/12/2010US20100204222 Pyridopyrimidine derivatives as p13 kinase inhibitors
08/12/2010US20100204216 PHARMACEUTICAL COMPOSITION FOR INHIBITING AMYLOID-beta PROTEIN ACCUMULATION
08/12/2010US20100204214 Histamine h3 inverse agonists and antagonists and methods of use thereof
08/12/2010US20100204213 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
08/12/2010US20100204203 Chemical Compounds 637: Pyridopyrimidinediones as PDE4 Inhibitors
08/12/2010US20100204201 Hiv integrase inhibitors
08/12/2010US20100204199 Cyclic 11-beta hydroxysteroid dehydrogenase type i inhibitors
1 ... 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 ... 646